Targeting Protein Kinase CK2 Suppresses Pro-survival Signaling Pathways and Growth of Glioblastoma.

CONCLUSIONS: CK2 inhibitors may be considered for treatment of patients with GBM.
PMID: 24036851 [PubMed - as supplied by publisher]

Source: Clinical Cancer Research - September 13, 2013 Category: Cancer & Oncology Authors: Zheng Y, McFarland BC, Drygin D, Yu H, Bellis SL, Kim H, Bredel M, Benveniste EN Tags: Clin Cancer Res Source Type: research